Fenske Jakob, Steffen Claudius, Mrosk Friedrich, Lampert Philipp, Nikolaidou Eirini, Beck Marcus, Heiland Max, Kreutzer Kilian, Doll Christian, Koerdt Steffen, Rendenbach Carsten
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Oral and Maxillofacial Surgery, Augustenburger Platz 1, Berlin 13353, Germany.
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Oral and Maxillofacial Surgery, Augustenburger Platz 1, Berlin 13353, Germany.
Radiother Oncol. 2025 Jan;202:110652. doi: 10.1016/j.radonc.2024.110652. Epub 2024 Nov 24.
With standard radiotherapy protocols after R0 resection of advanced local oral squamous cell carcinoma (OSCC) and primary reconstruction of segmental defects, a high radiation dose is applied to healthy tissue in autologous microvascular free flaps. Considering the potential consequences of flap complications and associated surgeries for patients, data is lacking on whether postoperative radiotherapy (PORT) of the flap volume is indicated at all.
Patients with segmental mandibular resection and immediate reconstruction with osseous free flaps due to advanced OSCC between 2012 and 2022 were analyzed retrospectively regarding overall (OS), disease-free survival (DFS), local failure-free survival (LFFS), the need for secondary surgeries as well as flap complications and compared between patients with and without PORT in a matched-pair approach with occurrence of flap complications as a primary endpoint.
105 patients matched the inclusion criteria. The maximum follow-up period was 60 months. 68 patients received PORT. 74 patients were included in the final analysis. No case of disease recurrence inside the free flap was recorded. There were no significant differences in DFS (p = 0.21), OS (p = 0.33) and LFFS (p = 0.6) between both cohorts. Occurrence of osteoradionecrosis (p = 0.03) and bone exposure (p = 0.003) was higher in irradiated flaps. In patients with PORT, the demand for secondary surgeries due to flap complications was significantly higher (p = 0.009). Radiation doses were not increased in patients with flap ORN.
PORT is associated with higher flap complications and need for secondary surgeries in advanced stage OSCC. Given a recurrence rate of zero inside the flap without PORT and the improbability of recurrence within healthy transplanted tissue, the usefulness of applying high radiation doses to this vulnerable tissue is questioned. Further refinements of RT planning should be evaluated and tested in a RCT trial.
在晚期局部口腔鳞状细胞癌(OSCC)行R0切除并对节段性缺损进行一期重建后,采用标准放疗方案时,自体微血管游离皮瓣中的健康组织会受到高剂量辐射。考虑到皮瓣并发症及相关手术对患者的潜在影响,目前尚无关于是否应对皮瓣区域进行术后放疗(PORT)的数据。
回顾性分析2012年至2022年间因晚期OSCC行节段性下颌骨切除并立即采用游离骨皮瓣重建的患者的总生存期(OS)、无病生存期(DFS)、局部无复发生存期(LFFS)、二次手术需求以及皮瓣并发症情况,并采用配对法比较接受PORT和未接受PORT的患者,将皮瓣并发症的发生作为主要终点。
105例患者符合纳入标准。最长随访期为60个月。68例患者接受了PORT。74例患者纳入最终分析。未记录到游离皮瓣内疾病复发的病例。两组患者的DFS(p = 0.21)、OS(p = 0.33)和LFFS(p = 0.6)无显著差异。放疗皮瓣的放射性骨坏死发生率(p = 0.03)和骨外露发生率(p = 0.003)更高。在接受PORT的患者中,因皮瓣并发症进行二次手术的需求显著更高(p = 0.009)。皮瓣ORN患者的放疗剂量未增加。
PORT与晚期OSCC患者更高的皮瓣并发症及二次手术需求相关。鉴于未接受PORT时皮瓣内复发率为零且健康移植组织内复发可能性不大,对这种脆弱组织施加高剂量辐射的有效性受到质疑。应在随机对照试验中评估和测试放疗计划的进一步优化。